KROS
Keros Therapeutics Inc
11.60$
+3.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | – | +1,687.5% | -42.0% | -55.4% | +948.6% | +684.0% | +6,844.3% | -91.4% | -21.5% | -97.3% | -4.7% | +4,850.4% | – | |
| – | -7.6% | -14.3% | +7.2% | +106.5% | -14.8% | +15.6% | +15.2% | -98.1% | +5,477.1% | -97.8% | +35.4% | +4.6% | +62.7% | -34.4% | +32.9% | +53.8% | -20.9% | +1.1% | -55.2% | +12.1% | +10.5% | +2.6% | +5.7% | +3.6% | +7.6% | +6.8% | +1.3% | +0.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -101.6% | – | – | – | – | – | – | – | -42.0% | -55.4% | +100.0% | +3,562.2% | +7,695.1% | -91.6% | -22.1% | -97.2% | -109.4% | – | – | |
| – | -7.6% | -14.3% | +8.0% | +104.9% | -14.8% | +15.6% | +15.2% | +18.8% | -13.2% | +48.6% | +27.0% | -4.0% | +28.8% | -9.6% | +18.2% | +25.0% | +4.6% | +4.9% | +9.8% | +2.0% | +5.9% | +21.5% | -7.3% | +6.7% | -10.7% | -55.1% | -8.2% | -10.1% | +38.7% | – | |
| – | +33.2% | +48.6% | +9.8% | +85.3% | +84.6% | -2.7% | +1.8% | +18.2% | +32.4% | -5.2% | +12.5% | +0.2% | +23.1% | -6.8% | +2.2% | +9.7% | +13.2% | +3.9% | -0.5% | +13.2% | -3.4% | -1.4% | +8.6% | -1.6% | +38.0% | -30.1% | +16.0% | -13.6% | -15.2% | – | |
| – | -3.9% | -6.3% | +8.3% | +100.9% | +3.9% | +9.5% | +11.2% | +18.6% | -64.1% | +257.0% | +21.6% | -1.8% | +27.4% | -9.0% | +14.2% | +21.6% | +6.3% | +3.4% | +9.0% | +4.2% | +3.9% | +16.4% | -4.7% | +5.8% | -2.7% | -49.2% | +1.4% | -12.9% | +19.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -126.2% | – | – | – | – | – | |
| – | +0.0% | +50.0% | -66.7% | +100.0% | -50.0% | +100.0% | -50.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +346,100.0% | +29.0% | -100.0% | +153,150.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.8% | – | – | – | – | – | |
| – | +0.0% | -60,950.0% | – | -107.5% | – | -15,700.0% | – | -39.0% | -258.0% | – | – | -99.9% | -346,300.0% | – | – | -153,350.0% | – | -105.5% | – | -107.3% | – | – | – | +3,247.7% | -122.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.7% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.